Clinical Trial: Efficacy, safety, quality of life in treating Seropositive non-Sjogren’s Syndrome Aqueous Deficiency Dry Eye with first-line topical cyclosporin 0.1%: a multicenter randomized controlled trial (China)

Posted On: 2026-10-12

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy, safety, quality of life in treating Seropositive non-Sjogren’s Syndrome Aqueous Deficiency Dry Eye with first-line topical cyclosporin 0.1%: a multicenter randomized controlled trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133982

Registration Time: 2026/10/09

Type: Interventional study

Primary Sponsor: Department of Ophthalmology and Visual Sciences (DOVS), Chinese University of Hong Kong

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=315118

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Efficacy, safety, quality of life in treating Seropositive non-Sjogren’s Syndrome Aqueous Deficiency Dry Eye with first-line topical cyclosporin 0.1%: a multicenter randomized controlled trial (China)